Congress can modernize our healthcare system by passing the SOAR Act and enabling beneficiaries to live on their terms with the help of supplemental oxygen.

The state's deadliest blaze in more than four decades has highlighted the lack of regulations governing assisted-living ...

Q1 2025 delivered first positive adjusted EBITDA result since 2021 and guided to a break-even adjusted EBITDA result for ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen ...

Inogen says Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet, pure, continuous flow oxygen in a compact and efficient design. It ...

Developed in collaboration with Yuwell Medical, Voxi 5 presents a viable option for patients seeking reliable stationary oxygen therapy, delivering 1-5 L/min of quiet 1, pure 2, continuous flow ...

Inogen, Inc. (Nasdaq: INGN ), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the launch of Voxi TM 5, a new stationary ...

GOLETA, Calif.--(BUSINESS WIRE)--Jun 23, 2025--Inogen, Inc. (Nasdaq: INGN ), a leading medical technology company specializing in innovative respiratory products for homecare use, today announced the ...

Discover Inogen's Q1 2025 earnings insights, featuring 5.5% revenue growth, B2B focus, UL Medical collaboration, and strategies for DTC stabilization and ...